Hidayet E Arat1, Virginie-Anne Chouinard2, Bruce M Cohen2, Kathryn E Lewandowski2, Dost Öngür3. 1. Dokuz Eylul University, Faculty of Medicine, Department of Psychiatry, Izmir, Turkey; McLean Hospital, 115 Mill St., Belmont, MA 02478, USA. 2. McLean Hospital, 115 Mill St., Belmont, MA 02478, USA; Harvard Medical School, Department of Psychiatry, Boston, MA 02114, USA. 3. McLean Hospital, 115 Mill St., Belmont, MA 02478, USA; Harvard Medical School, Department of Psychiatry, Boston, MA 02114, USA. Electronic address: dongur@partners.org.
Abstract
OBJECTIVES: White matter (WM) abnormalities are one of the most widely and consistently reported findings in schizophrenia (SZ) and bipolar disorder (BD). If these abnormalities are inherited determinants of illness, suitable to be classified as an endophenotype, relatives of patients must also have them at higher rate compared to the general population. In this review, we evaluate published diffusion tensor imaging (DTI) studies comparing first degree relatives of SZ and BD patients and healthy control subjects. METHODS: We searched PubMed, Embase and PsychInfo for DTI studies which included an unaffected relative and a healthy comparison group. RESULTS: 22 studies fulfilled the inclusion criteria. WM abnormalities were found in many diverse regions in relatives of SZ patients. Although the findings were not completely consistent across studies, the most implicated areas were the frontal and temporal WM regions and the corpus callosum. Studies in relatives of BD patients were fewer in number with less consistent findings reported across studies. CONCLUSIONS: Our review supports the concept of WM abnormalities as an endophenotype in SZ, with somewhat weaker evidence in BD, but larger and higher quality studies are needed to make a definitive comment.
OBJECTIVES:White matter (WM) abnormalities are one of the most widely and consistently reported findings in schizophrenia (SZ) and bipolar disorder (BD). If these abnormalities are inherited determinants of illness, suitable to be classified as an endophenotype, relatives of patients must also have them at higher rate compared to the general population. In this review, we evaluate published diffusion tensor imaging (DTI) studies comparing first degree relatives of SZ and BDpatients and healthy control subjects. METHODS: We searched PubMed, Embase and PsychInfo for DTI studies which included an unaffected relative and a healthy comparison group. RESULTS: 22 studies fulfilled the inclusion criteria. WM abnormalities were found in many diverse regions in relatives of SZ patients. Although the findings were not completely consistent across studies, the most implicated areas were the frontal and temporal WM regions and the corpus callosum. Studies in relatives of BDpatients were fewer in number with less consistent findings reported across studies. CONCLUSIONS: Our review supports the concept of WM abnormalities as an endophenotype in SZ, with somewhat weaker evidence in BD, but larger and higher quality studies are needed to make a definitive comment.
Authors: S Muñoz Maniega; G K S Lymer; M E Bastin; D Marjoram; D E Job; T W J Moorhead; D G Owens; E C Johnstone; A M McIntosh; S M Lawrie Journal: Schizophr Res Date: 2008-10-11 Impact factor: 4.939
Authors: Owen R Phillips; Keith H Nuechterlein; Robert F Asarnow; Kristi A Clark; Ryan Cabeen; Yaling Yang; Roger P Woods; Arthur W Toga; Katherine L Narr Journal: Biol Psychiatry Date: 2011-05-14 Impact factor: 13.382
Authors: Emma Sprooten; Jessika E Sussmann; April Clugston; Anna Peel; James McKirdy; T William J Moorhead; Seonaid Anderson; Allen J Shand; Stephen Giles; Mark E Bastin; Jeremy Hall; Eve C Johnstone; Stephen M Lawrie; Andrew M McIntosh Journal: Biol Psychiatry Date: 2011-03-23 Impact factor: 13.382
Authors: Xiaobo Li; Craig A Branch; Hilary C Bertisch; Kyle Brown; Kamila U Szulc; Babak A Ardekani; Lynn E DeLisi Journal: Schizophr Res Date: 2007-02-16 Impact factor: 4.939
Authors: Hilary Bertisch; Dawei Li; Matthew J Hoptman; Lynn E Delisi Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2010-06-05 Impact factor: 3.568
Authors: Heleen B M Boos; René C W Mandl; Neeltje E M van Haren; Wiepke Cahn; G Caroline M van Baal; René S Kahn; Hilleke E Hulshoff Pol Journal: Eur Neuropsychopharmacol Date: 2012-07-26 Impact factor: 4.600
Authors: Jean A Frazier; Janis L Breeze; George Papadimitriou; David N Kennedy; Steven M Hodge; Constance M Moore; James D Howard; Michael P Rohan; Verne S Caviness; Nikos Makris Journal: Bipolar Disord Date: 2007-12 Impact factor: 6.744
Authors: Katherine H Karlsgodt; Theo G M van Erp; Russell A Poldrack; Carrie E Bearden; Keith H Nuechterlein; Tyrone D Cannon Journal: Biol Psychiatry Date: 2007-08-27 Impact factor: 13.382
Authors: Francesco Carletti; James B Woolley; Sagnik Bhattacharyya; Rocio Perez-Iglesias; Paolo Fusar Poli; Lucia Valmaggia; Matthew R Broome; Elvira Bramon; Louise Johns; Vincent Giampietro; Steve C R Williams; Gareth J Barker; Philip K McGuire Journal: Schizophr Bull Date: 2012-04-03 Impact factor: 9.306
Authors: G Roberts; A Perry; A Lord; A Frankland; V Leung; E Holmes-Preston; F Levy; R K Lenroot; P B Mitchell; M Breakspear Journal: Mol Psychiatry Date: 2016-12-20 Impact factor: 15.992
Authors: Janice M Fullerton; Paul Klauser; Rhoshel K Lenroot; Alex D Shaw; Bronwyn Overs; Anna Heath; Murray J Cairns; Joshua Atkins; Rodney Scott; Peter R Schofield; Cyndi Shannon Weickert; Christos Pantelis; Alex Fornito; Thomas J Whitford; Thomas W Weickert; Andrew Zalesky Journal: Transl Psychiatry Date: 2018-01-22 Impact factor: 6.222
Authors: Felix L Nägele; Ofer Pasternak; Lisa V Bitzan; Marius Mußmann; Jonas Rauh; Marek Kubicki; Gregor Leicht; Martha E Shenton; Amanda E Lyall; Christoph Mulert Journal: World J Biol Psychiatry Date: 2020-07-09 Impact factor: 4.132